Neuro-Oncological Ventral Antigen 1 (NOVA1) Peptide
NOVA1
Reactivity: Human
Host: Synthetic
BP, Imm
Quick Overview for Neuro-Oncological Ventral Antigen 1 (NOVA1) Peptide (ABIN369762)
Target
NOVA1
(Neuro-Oncological Ventral Antigen 1 (NOVA1))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Immunogen (Imm)
-
-
Sequence
- REMPQNVAKT EPVS
-
Characteristics
- The peptide was used in the production of ABIN369762 - Goat Anti-NOVA1 Antibody. It is currently untested in blocking applications.
-
-
-
-
Application Notes
- When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
-
Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
-
Storage
- -20 °C
-
Storage Comment
- Shipped at ambient temperature, store at -20°C.
-
-
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
Target
-
You are here:
